BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32920141)

  • 41. Discovery of Amide-Functionalized Benzimidazolium Salts as Potent α-Glucosidase Inhibitors.
    Khan IA; Ahmad M; Ashfaq UA; Sultan S; Zaki MEA
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
    Wang G; Wang J; He D; Li X; Li J; Peng Z
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of highly potent α-glucosidase inhibitory and antioxidant constituents from Zizyphus rugosa bark: enzyme kinetic and molecular docking studies with active metabolites.
    Sichaem J; Aree T; Lugsanangarm K; Tip-Pyang S
    Pharm Biol; 2017 Dec; 55(1):1436-1441. PubMed ID: 28320255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
    Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
    Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coumarin-based Scaffold as α-glucosidase Inhibitory Activity: Implication for the Development of Potent Antidiabetic Agents.
    Tafesse TB; Bule MH; Khoobi M; Faramarzi MA; Abdollahi M; Amini M
    Mini Rev Med Chem; 2020; 20(2):134-151. PubMed ID: 31553294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and studies of thiazolidinedione-isatin hybrids as α-glucosidase inhibitors for management of diabetes.
    Kaur R; Kumar R; Dogra N; Kumar A; Yadav AK; Kumar M
    Future Med Chem; 2021 Mar; 13(5):457-485. PubMed ID: 33506699
    [No Abstract]   [Full Text] [Related]  

  • 47. Towards multi-target antidiabetic agents: In vitro and in vivo evaluation of 3,5-disubstituted indolin-2-one derivatives as novel α-glucosidase inhibitors.
    Klochkov VG; Bezsonova EN; Dubar M; Melekhina DD; Temnov VV; Zaryanova EV; Lozinskaya NA; Babkov DA; Spasov AA
    Bioorg Med Chem Lett; 2022 Jan; 55():128449. PubMed ID: 34780899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study on the Interaction of 1,5-diaryl Pyrrole Derivatives with α- glucosidase; Synthesis, Molecular Docking, and Kinetic Study.
    Tafesse TB; Moghadam ES; Bule MH; Faramarzi MA; Abdollahi M; Amini M
    Med Chem; 2021; 17(5):545-553. PubMed ID: 31808390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
    Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
    Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and synthesis of novel quinazolinone-pyrazole derivatives as potential α-glucosidase inhibitors: Structure-activity relationship, molecular modeling and kinetic study.
    Azimi F; Azizian H; Najafi M; Hassanzadeh F; Sadeghi-Aliabadi H; Ghasemi JB; Ali Faramarzi M; Mojtabavi S; Larijani B; Saghaei L; Mahdavi M
    Bioorg Chem; 2021 Sep; 114():105127. PubMed ID: 34246971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Indole acrylonitriles as potential anti-hyperglycemic agents: Synthesis, α-glucosidase inhibitory activity and molecular docking studies.
    Solangi M; Kanwal ; Mohammed Khan K; Saleem F; Hameed S; Iqbal J; Shafique Z; Qureshi U; Ul-Haq Z; Taha M; Perveen S
    Bioorg Med Chem; 2020 Nov; 28(21):115605. PubMed ID: 33065441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives.
    Hussain F; Khan Z; Jan MS; Ahmad S; Ahmad A; Rashid U; Ullah F; Ayaz M; Sadiq A
    Bioorg Chem; 2019 Oct; 91():103128. PubMed ID: 31369977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyanoacetohydrazide linked to 1,2,3-triazole derivatives: a new class of α-glucosidase inhibitors.
    Iraji A; Shareghi-Brojeni D; Mojtabavi S; Faramarzi MA; Akbarzadeh T; Saeedi M
    Sci Rep; 2022 May; 12(1):8647. PubMed ID: 35606520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of diethyl 4-substituted-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylates as a new series of inhibitors against yeast α-glucosidase.
    Niaz H; Kashtoh H; Khan JA; Khan A; Wahab AT; Alam MT; Khan KM; Perveen S; Choudhary MI
    Eur J Med Chem; 2015 May; 95():199-209. PubMed ID: 25817770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
    Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM
    Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening.
    Thakral S; Singh V
    Med Chem; 2019; 15(2):186-195. PubMed ID: 30251608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utilization of the common functional groups in bioactive molecules: Exploring dual inhibitory potential and computational analysis of keto esters against α-glucosidase and carbonic anhydrase-II enzymes.
    Khan I; Khan A; Halim SA; Khan M; Zaib S; Al-Yahyaei BEM; Al-Harrasi A; Ibrar A
    Int J Biol Macromol; 2021 Jan; 167():233-244. PubMed ID: 33249154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro α-Glucosidase Inhibition by Non-sugar based Triazoles of Dibenzoazepine, their Structure-Activity Relationship, and Molecular Docking.
    Khan MA; Javaid K; Wadood A; Jamal A; Batool F; Fazal-Ur-Rehman S; Basha FZ; Choudhary MI
    Med Chem; 2017; 13(7):698-704. PubMed ID: 28745232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
    Wang G; Chen M; Qiu J; Xie Z; Cao A
    Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.